Multiple Myeloma

What is Multiple Myeloma?

Multiple myeloma is a form of cancer that affects the bone marrow. The cancer is also called Kahler’s disease, named after an Austrian pathologist called Otto Kahler who first described the condition.

Read More

Overview

Feature Articles

Latest Multiple Myeloma News and Research

Research reveals novel way to treat cancers using CAR T cell therapy

Research reveals novel way to treat cancers using CAR T cell therapy

AMSBIO announces new Custom CAR-T development service

AMSBIO announces new Custom CAR-T development service

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

SU2C announces international team for fighting gastric cancer

SU2C announces international team for fighting gastric cancer

Daratumumab proves effective in patients with relapsed AL amyloidosis

Daratumumab proves effective in patients with relapsed AL amyloidosis

The Riney Family Multiple Myeloma Initiative to be established at Dana-Farber

The Riney Family Multiple Myeloma Initiative to be established at Dana-Farber

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

New combination therapy can lead to durable responses in patients with multiple myeloma

New combination therapy can lead to durable responses in patients with multiple myeloma

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Novel agent opens up new treatment option for patients with refractory myeloma

Novel agent opens up new treatment option for patients with refractory myeloma

Cancer patients have higher risk of cardiovascular death

Cancer patients have higher risk of cardiovascular death

Risk of death from heart disease found to be higher in cancer patients

Risk of death from heart disease found to be higher in cancer patients

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

New device separates malignant plasma cells from normal ones

New device separates malignant plasma cells from normal ones

New microfluidics device detects malignant multiple myeloma cells in blood

New microfluidics device detects malignant multiple myeloma cells in blood

Gene-editing technique CRISPR trialed for first time as cancer treatment

Gene-editing technique CRISPR trialed for first time as cancer treatment

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

Cancer drug may delay progression of bone and other myeloma-related organ damage

Cancer drug may delay progression of bone and other myeloma-related organ damage